4 unchanged sentences
2022 $ 1.20 $ 1.20 $ 1.20 $ 1.20
−Removed: The cash dividends declared during the second quarter of 2021 include a special dividend of $3.00 per share that was declared in June 2021 and paid in July 2021.
−Removed: Our common stockholders have approved all of our equity-based compensation plans.
−Removed: These plans provide for the following issuances of shares of our common stock at December 31, 2022:
−Removed: Employee and non-employee director plans Employee stock purchase plan Total
−Removed: Exercise of outstanding options 2,218,506 — 2,218,506
−Removed: Settlement of outstanding restricted stock units 5,996,539 — 5,996,539
−Removed: Future issuances 10,437,953 907,014 11,344,967
−Removed: Total 18,652,998 907,014 19,560,012
−Removed: The outstanding options included in the table above have a weighted-average exercise price of $74.31.
−Removed: Under the terms of the 2020 Long-Term Incentive Plan, approved by stockholders in May 2020, and the 2012 Long-Term Incentive Plan, the number of shares provided and available for future issuance will increase as we repurchase common stock in the future with the proceeds from stock option exercises.
−Removed: No shares have been issued under our Employee Stock Purchase Plan since its inception;
−Removed: all shares have been purchased in the open market.
+Added: See Part III, Item 12.
+Added: "Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters" for information relating to shares authorized for issuance under our equity compensation plans.
The following table presents repurchase activity during the fourth quarter of 2023.
4 unchanged sentences
part of publicly
−Removed: announced program Maximum number of
+Added: announced program (1)
+Added: Maximum number of
shares that may yet
4 unchanged sentences
Total 1,049,317 $ 100.34 1,028,863
−Removed: Shares repurchased by us in a quarter may include repurchases conducted pursuant to publicly announced board authorizations, outstanding shares surrendered to the company to pay the exercise price in connection with swap exercises of employee stock options and shares withheld to cover the minimum tax withholding obligation associated with the vesting of restricted stock awards.
+Added: (1) In March 2020, the Board approved a share repurchase program of approximately 24.1 million shares.
+Added: The share repurchase program does not have an expiration date.
+Added: Shares repurchased by us in a quarter may include repurchases conducted pursuant to publicly announced board authorizations, outstanding shares surrendered to the firm to pay the exercise price in connection with swap exercises of employee stock options and shares withheld to cover the minimum tax withholding obligation associated with the vesting of restricted stock awards.
Of the total number of shares purchased during the fourth quarter of 2023, 20,454 were related to shares surrendered in connection with employee stock option exercises and none were related to shares withheld to cover tax withholdings associated with the vesting of restricted stock awards.
−Removed: The following table details the changes in and status of the Board of Directors’ outstanding publicly announced board authorizations.
+Added: The following table details the changes in and status of the Board of Directors’ outstanding publicly announced authorization.
Authorization dates 12/31/2022 Additional shares authorized Total number of
shares purchased Maximum number of shares that may yet be purchased at 12/31/2023
−Removed: February 2019 525,910 — (525,910) —
March 2020 8,775,217 — (2,426,700) 6,348,517
−Removed: 15,525,910 — (6,750,693) 8,775,217
We have 940 stockholders of record and approximately 478,000 beneficial stockholder accounts held by brokers, banks, and other intermediaries holding our common stock.
−Removed: Common stock owned outright by our associates and directors, combined with outstanding vested stock options and unvested restricted stock awards, total approximately 7.4% of our outstanding stock and outstanding vested stock options at December 31, 2022.
+Added: Common stock owned outright by our associates and directors, combined with outstanding vested stock options and unvested restricted stock awards, total nearly 7% of our outstanding stock and outstanding vested stock options at December 31, 2023.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.